Camber Capital Corp logo

Camber Capital Corp

North America, Massachusetts, United States, Boston

Description

Camber Capital Corp is a privately owned hedge fund sponsor that provides its services to pooled investment vehicles.

Investor Profile

Camber Capital Corp has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Switzerland, United States.
  • Strong thematic focus on Biotechnology, Medical, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • Switzerland (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Beauty
  • Health Care
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Camber Capital Corp frequently co-invest with?

Principal Global Investors
North America, Iowa, United States, Des Moines
Co-Investments: 1
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
Suvretta Capital Management
North America, New York, United States, New York
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
FK
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Camber Capital Corp?

HydraFacial

Long Beach, California, United States

HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.

BeautyHealth CareManufacturingMedical Device
Post Ipo EquityMay 6, 2021
Amount Raised: $350,000,000
Molecular Partners

Zürich, Zurich, Switzerland

Molecular Partners is a clinical-stage biopharmaceutical company.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityJul 6, 2020
Amount Raised: $85,138,004